(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIOCENCE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BIOCENCE

ST13

US500000077842866

Classe

1

Pedido

77842866

Registro

4071102

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

46

Atualização mais recente

27/01/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1

Data de depósito

06/10/2009

Data de registro

13/12/2011

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/01/2022

Última transação

27/01/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Primeiro uso

17/01/2008

Primeiro uso no comércio

17/01/2008

Código do desenho

4

Tipo de titular

01

Localização do titular

Prosper, TX, US

Examinador

BROWNE, DAYNA

Unidade examinadora

L40

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

Lord, Allan Dale
Lord, Allan Dale

Representantes

William J. Benman Benman, Brown & Williams

Classificação técnica

Classes Nice

Classe 1

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical preservatives for use in the production of a wide variety of chemicalsPreservatives for pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Bacillus anthracisAnthraxBacillus cereusB. cereus food poisoningClostridium botulinumBotulismClostridium perfringensClostridialmyonecrosis (gas gangrene)Clostridium tetaniTetanus (lockjaw)Corynebacteriuni diphtheriaDiphtheriaEscherichia coliDiarrheaKlebsiella pneumoniaBronchopneumoniaLegionellapneumophilaLegionnaire's diseaseMycobacterium lepraeLeprosyMycobacteriumtuberculosisTuberculosisSalmonella speciesSalmonellaSalmonella typhiTyphoid feverSalmonella typhimuriumSalmonella gastroenteritisShigella dysenteriaeBacillary dysenteryShigella speciesShigellosisYersinia enterocoliticaYersiniosisgastroenteritisYersiniapestisPlagueYersinia pseudotuberculosisMesenteric lymphadenitisChlamydiaChlamydiatrachomatisTrachomaurethritiscervicitisconjunctivitisBordetella pertussis(whooping cough)Brucella speciesUndulant feverHemophilus influenzaMeningitisbacterial pneumoniaHemophilus pertussis(whooping cough)Neisseria gonorrhoeaeGonorrheapelvicinflammatory diseaseNeisseria meningitidesMeningitisStaphylococcus aureusPneumoniatoxic shock syndromeskin infectionsmeningitisStreptococcus pneumoniaPneumoniaear infectionsmeningitisStreptococcus pyogenesStrep throatrheumatic feverStreptococcusspeciesScarlet feverpuerperal feverListeria monocytogenesListeriosisperinatal septicemiameningitisencephalitisintrauterine infectionsMycoplasma pneumoniaPneumoniaRickettsia prowazekiiEpidemic typhusBrill-Zinsser disease (spread by lice)RickettsiarickettsiiRocky Mountain spotted fever (spread by ticks)Rickettsia typhiEndemic typhus (murine typhusspread by rat fleas)Campylobacter fetus jejuniCampylobacteriosis (bacterial diarrheal illness)Spirillum minorRat-bite feverSpirochete Treponema pallidumSyphilisAeromonas hydrophilaGastroenteritissepticemiacellulitiswound infectionsurinary tractinfectionsPlesiomonas shigelloidesGastroenteritisdiarrheaVibrio cholerae 01EpidemiccholeraVibrio cholerae 01GastroenteritisVibrio parahemolyticusV. parahemolyticus associated gastroenteritisVibrio vulnificusWound infectionsgastroenteritisprimarysepticemiaShigella flexneriS. dysenteriaVibrio choleraSalmonella typhiSalmonellaEnterotoxigenic Escherichia coliEnterococcus faecalisB. anthracis Pseudomonas aeruginosaMycobacterium chelonaeCandida albicansCampylobacterMycobacterium tuberculosisDiarrhoeal diseasesrespiratory tract infectionsmeningitissexually transmitted infectionsStreptococcus pneumoniaevancomycin-resistant enterococcimethicillin-resistant Staphylococcus aureusmulti-resistant salmonellaeClostridium difficile and multi-resistant Mycobacteriumtuberculosis and emerging Infectious DiseasesVirucidal disease and conditions of InfluenzaBird HiNI HIIYherpes simplex virus type 1 and type 2AvianFluFoot and Mouth diseaseEbola virusPox virusSmallpox virusTalfan disease virusSindbis virusAdenovirus (Common cold)BunyavirusHantaanLa CrosseSin Nombre (Kidney failure)Encephalitis (brain infection)Lung syndromeCalicivirus Norwalk Gastroenteritis (diarrheavomiting)Coronavirus (Corona Common cold)Filovirus EbolaMarburg Hemorrhagic (fever)Hemorrhagic (fever)Flavivirus Hepatitis C (non-Anon-B): Yellow fever (Hepatitis)HepatitishemorrhageHepadnavirus Hepatitis B virus (I-IBV)Hepatitisliver carcinomaHerpesvirusCytomegalovirusEpstein-Barr virus (EBV)Herpes simplex type 1Herpes simplex type 2Human herpesvirus 8 (HHV8)Varicella-zosterBirthdefectsMononucleosisnasopharyngeal carcinomaCold soresGenital lesionsKaposi'ssarcomaChicken poxshinglesOrthomyxovirusInfluenza types A and B FluPapovavirusHuman papillomavirus (ITPV)Wartscervical carcinomaPicornavirusCoxsackie virusEchovirusHepatitis APoliovirusRhinovirusMyocarditis (heart muscle infection)MeningitisInfectious hepatitisPoliomyelitisCommon coldParamyxovirusMeaslesMumpsParainfluenzaMeaslesMumpsear infectionsParvovirusB 19 Fifth diseasechronic anemiaPoxvirus Orthopoxvirus Smallpox (eradicated)Reovirus RotavirusDiarrheaRetrovirusHuman immunodeficiency virus (HIV)Human T-cell leukemia virus(HTLV-l)Acquiredimmunodeficiency syndrome (AIDS)Adult T-cell leukemialymphomaneurologic diseaseRhabdovirusRabiesTogavirusEastern equine encephalomyelitisEncephalitisRubellabirth defects

Publicações

Histórico de despachos e eventos da marca no USPTO.

46 publicações encontradas

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

27/01/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

27/01/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

27/01/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

27/01/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

18/08/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

13/12/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

19/05/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

19/05/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

18/05/2017

E815

TEAS SECTION 8 & 15 RECEIVED

06/04/2017

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

25/09/2012

MAIL

PAPER RECEIVED

06/09/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

13/12/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

08/11/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

07/11/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/11/2011

DOCK

ASSIGNED TO EXAMINER

02/11/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

27/10/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

24/10/2011

IUAF

USE AMENDMENT FILED

21/10/2011

EISU

TEAS STATEMENT OF USE RECEIVED

21/10/2011

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

24/05/2011

PUBO

PUBLISHED FOR OPPOSITION

29/03/2011

NPUB

NOTICE OF PUBLICATION

09/03/2011

MREI

NOTICE OF REINSTATEMENT MAILED

25/02/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

24/02/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/02/2011

ACEC

AMENDMENT FROM APPLICANT ENTERED

23/02/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/02/2011

RGIA

REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED

22/02/2011

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

16/02/2011

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

16/02/2011

CNFR

FINAL REFUSAL MAILED

21/07/2010

CNFR

FINAL REFUSAL WRITTEN

21/07/2010

ACEC

AMENDMENT FROM APPLICANT ENTERED

20/07/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/07/2010

ALIE

ASSIGNED TO LIE

20/07/2010

MAIL

PAPER RECEIVED

09/07/2010

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

24/02/2010

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

24/02/2010

CNRT

NON-FINAL ACTION MAILED

08/01/2010

CNRT

NON-FINAL ACTION WRITTEN

07/01/2010

DOCK

ASSIGNED TO EXAMINER

05/01/2010

MPMK

NOTICE OF PSEUDO MARK MAILED

15/10/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/10/2009

NWAP

NEW APPLICATION ENTERED

09/10/2009

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIOCENCE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.